Contact Programme Register Home

Home
Scientific Advisory Committee
Sponsors
Exhibition
Sponsorship booklet
Delegate Login
Registration
Programme
Sessions
Abstracts
COPD5 Abstracts
COPD6 Abstracts
Biographies
Gallery
Contact Us
Privacy
Dates to Remember


Translate text to:
German Spanish
French Italian
Portugese Portugese

Google

 

COPD5 Abstracts:

 

  1. Mortality Predictors
  2. Indacaterol
  3. Effectiveness of an Outreach
  4. Initiating Health Forecasting
  5. Indacaterol (2nd)
  6. How difference measures of cold weather
  7. Improved COPD Management
  8. Stratification of COPD
  9. The use of health forecasting in a UK
  10. Socioeconomic indices v1
  11. Preventing Mortality
  12. Hemodynamic Effect
  13. Hypertonic Saline
  14. Qualitative responses
  15. Determinants
  16. Plymouth COPD Audit
  17. Pulmonary Rehabilitation
  18. St Georges Respiratory
  19. Severe COPD
  20. Comorbid conditions and quality of life
  21. Lung Function
  1. Feasibility of Swimming
  2. Oxygen Assessment
  3. The Effect of Current Cigarette ...
  4. High Sensitivity
  5. Pulmonary Inflammatory
  6. Estimating the Potential
  7. Roflumilast
  8. Serum Secretory
  9. Tolerability and Safety
  10. Evaluation of COPD
  11. Human Gene
  12. Add-on Selenium
  13. Is Community Based ...
  14. Perceived Health Benefit ...
  15. The Effect of the Individual Practitioner
  16. What is Wrong ...
  17. Remote Electronic Reporting of Primary
  18. Effect of Romlumilast ...
  19. Passive smoking exposure ...
  20. Prevelance of under-diagnosis of COPD ...

Gold Sponsors of COPD Link to Boehringer-ingelheim Link to Pfizer Link to NYCOMED Link to MSD Link to GSK (including Allen and Hanbury's Link to Dates to Remember Year of the Lung Link

               home | register | programme | contact us | privacy